Citadel Advisors
SOPH icon

Citadel Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Citadel Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+38,497
New +$195K ﹤0.01% 11822
2025
Q4 		– Sell
-12,320
Closed -$58.6K – 13974
2025
Q3 		$58.6K Sell
12,320
-26,791
-68% -$92.1K ﹤0.01% 12116
2025
Q2 		$121K Buy
39,111
+26,976
+222% +$80.4K ﹤0.01% 11152
2025
Q1 		$40.3K Sell
12,135
-8,451
-41% -$29.7K ﹤0.01% 12538
2024
Q4 		$64.2K Buy
20,586
+5,094
+33% +$17.3K ﹤0.01% 12100
2024
Q3 		$56.3K Buy
+15,492
New +$62.9K ﹤0.01% 11778
2024
Q1 		– Sell
-20,174
Closed -$95K – 15382
2023
Q4 		$95K Sell
20,174
-2,805
-12% -$10.5K ﹤0.01% 10994
2023
Q3 		$58.6K Sell
22,979
-23,710
-51% -$75.2K ﹤0.01% 11565
2023
Q2 		$209K Sell
46,689
-20,599
-31% -$93.1K ﹤0.01% 9787
2023
Q1 		$334K Buy
67,288
+36,012
+115% +$117K ﹤0.01% 9158
2022
Q4 		$64.4K Sell
31,276
-27,035
-46% -$60.7K ﹤0.01% 11814
2022
Q3 		$153K Buy
+58,311
New +$204K ﹤0.01% 10679
2022
Q1 		– Sell
-14,194
Closed -$200K – 14508
2021
Q4 		$200K Buy
+14,194
New +$209K ﹤0.01% 11855

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Citadel Advisors's SOPH Position: Q2 2026 in Review

Citadel Advisors opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 38,497 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #11822 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in SOPH as recently as Q3 2025.

Citadel Advisors first reported a position in SOPH in Q4 2021 and has held it in 13 quarters since. The position peaked at $334K in Q1 2023. 71 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Citadel Advisors held 38,497 shares of SOPHiA GENETICS worth $222K as of Q2 2026.
  • SOPHiA GENETICS was a new Citadel Advisors position in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11822 holding.
  • Citadel Advisors first reported a position in SOPHiA GENETICS in Q4 2021 and has held it in 13 quarters since.
  • Citadel Advisors's SOPHiA GENETICS position peaked at $334K in Q1 2023.
  • 71 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.